The World Vaccine Congress is one of the largest conferences dedicated to vaccines, covering a wide range of topics from vaccine science and research, to manufacturing and policy, and more. USP is proud to serve as a gold sponsor for this year’s meeting.
USP participation
Facilitating Global Access to Quality mRNA and Viral Vector Vaccine Products: Advances toward analytical tools to ensure quality, safety and benefit
Wednesday, April 5, 12:40 pm EST
USP will present updated guidelines for quality mRNA vaccines, highlight progress toward additional guidelines for viral vectored vaccines, and share our newly released and expanded vaccine toolkits.
Speaker: John Cipollo, Senior Principal Scientist, USP
Strengthening African Regulatory Agencies to Enhance Availability of Quality Vaccines
Thursday, April 6, 10:10 am EST
From emergency use authorization and registration to safety monitoring and surveillance, USP will share its work with national regulatory authorities across Africa to advance regulatory maturity, strengthen national quality control laboratories, and improve access to vaccines in low- and middle-income countries.
Speaker: Laura Martin, Vaccines Program Director, Global Health Technical Programs, USP
Download the full program and register: https://www.terrapinn.com/wvcdc
Not able to join? Follow us @USPGlobalHealth for updates. #WVCUSA
Expanding capacity to produce vaccines in Africa
Read the white paper
Get the latest updates on global health projects
Sign up for our newsletter